Black Diamond Therapeutics Inc (BDTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BDTX Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Black Diamond Therapeutics Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent30.07
Available-for-sale Securities, Debt Securities, Current MA88.19
Cash & Short-term Investments118.00
Prepaid Expense And Other Assets Current4.71
Total Current Assets122.97
Equipment/Property/Plant Net0.34
Other Assets, Noncurrent9.62
Restricted Cash Noncurrent0.83
Operating Lease Right Of Use Asset8.76
Total Assets132.92
Liabilities
Accounts Payable, Current AC2.97
Accrued Liabilities, Current AC11.57
Other Liabilities, Current0.00
Total Current Liabilities14.53
Total Long-term Debt0.00
Other liabilities, Noncurrent14.09
OperatingLeaseLiabilityNoncurrent14.09
Total Liabilities28.62
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock578.10
Retained Earnings / Accumulated Deficit-473.78
Other Equity-0.04
Common Stockholder's Equity104.30
Total Stockholder's Equity104.30
Liabilities & Stockholder's Equity132.92
4 historic quarters locked

Sign in to unlock the full Black Diamond Therapeutics Inc balance sheet history.

About Black Diamond Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001701541-26-000025

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.